Product NDC: | 0904-5448 |
Proprietary Name: | PENTOXIFYLLINE |
Non Proprietary Name: | PENTOXIFYLLINE |
Active Ingredient(s): | 400 mg/1 & nbsp; PENTOXIFYLLINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-5448 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075191 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040216 |
Package NDC: | 0904-5448-61 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0904-5448-61) |
NDC Code | 0904-5448-61 |
Proprietary Name | PENTOXIFYLLINE |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0904-5448-61) |
Product NDC | 0904-5448 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PENTOXIFYLLINE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20040216 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | PENTOXIFYLLINE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |